In Focus: The Future of Aesthetics

Physician Growth Partners Advises on Women’s Health Partnership in Chicago

Through a new partnership, Together Women’s Health, a portfolio company of Shore Capital Partners, has entered into the Chicago market and will empower The Northwestern Specialists for Women with significant resources to continue its growth. Physician Growth Partners served as the exclusive transaction advisor to The Northwestern Specialists for Women in its evaluation, negotiation, and execution of this transaction.

The Northwestern Specialists for Women is led by five shareholders: Dr. Bonnie Wise, Dr. Kim McMahon, Dr. Dayna Salasche, Dr. Seema Venkatachalam, and Dr. Melissa Dugan-Kim. Since its founding in 2008, NSW has grown to become one of the preeminent providers of comprehensive women’s health services in Chicago.

TWH will provide the resources and management support to enable NSW to continue to thrive for years to come. Dr. Bonnie Wise will join TWH as Chief Medical Officer of the platform.

Revision Skincare, RVL Pharmaceuticals Form Partnership

Revision Skincare is partnering with RVL Pharmaceuticals, Inc. the owner of UPNEEQ, to collaborate on a variety of marketing efforts within the medical aesthetics industry, working together to address significant unmet consumer needs.

Revisions says that, with shared values and visions for business growth and an expanding footprint, the collaboration aligns two game-changing brands to offer more accessible solutions to aesthetic patients and providers nationwide.

For more than two decades, Revision Skincare has been at the forefront of physician-dispensed brands. RVL Pharmaceuticals offers appropriate patients a nonsurgical solution for acquired ptosis with Upneeq, the first and only FDA-approved prescription eye drop for the treatment of acquired ptosis in adults.

Through the partnership, Revision Skincare and RVL Pharmaceuticals will bring broader access to products like D·E·J Eye Cream, Revox Line Relaxer, and UPNEEQ.

BuildMyHealth Names First Chief Revenue Officer

BuildMyHealth, developer of the No Surprises Act price transparency and lead conversion platform, has its first Chief Revenue Officer. Chad Sawyer was previously a national sales executive with both Crystal Clear Digital Marketing and Patient Now. In those roles, Mr. Sawyer helped hundreds of practices integrate the Crystal Clear and Patient Now products into their websites and daily work flow.

“With the No Surprises Act, the Federal government is outlawing surprise bills and emphasizing price transparency in urgent and elective aspects of health care. BuildMyHealth’s focus has always been price transparency, and now we have a mandate on the Federal level,” says Jonathan Kaplan, MD, founder/CEO of BuildMyHealth, and board certified plastic surgeon.

“That’s why we’re so excited to have Chad on board. His sales acumen, experience and charisma will provide the escape velocity at this critical juncture in our growth.”

Information about BuildMyHealth’s price transparency platform or the No Surprises Act is available online.

CARE Curriculum Launched by DREAM Initiative from Allergan Aesthetics, SkinBetter Science

The DREAM Initiative, developed by Allergan Aesthetics and skinbetter science, has supported the development of a racial equity curriculum for dermatology residency programs. The Curriculum for Advancing Racial Equity (CARE), developed by Solomé Rose Consulting, LLC, is designed to equip physicians with the tools and knowledge to address the impact of racism in medicine.

The DREAM Initiative (Driving Racial Equity in Aesthetic Medicine) seeks to address the multiple effects of systemic racism in aesthetic medicine through educational efforts and awareness-raising initiatives.